Kavar Capital Partners Group, LLC Abbott Laboratories Transaction History
Kavar Capital Partners Group, LLC
- $590 Million
- Q4 2024
A detailed history of Kavar Capital Partners Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Kavar Capital Partners Group, LLC holds 41,757 shares of ABT stock, worth $5.38 Million. This represents 0.8% of its overall portfolio holdings.
Number of Shares
41,757
Previous 41,927
0.41%
Holding current value
$5.38 Million
Previous $4.78 Million
1.19%
% of portfolio
0.8%
Previous 0.76%
Shares
17 transactions
Others Institutions Holding ABT
# of Institutions
3,217Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$21.6 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$16.9 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$9.88 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$8.47 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.87 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $226B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...